Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05636020 · ClinicalTrials.gov registry record · NA

Intervention to Change Affect Recognition and Empathy

A NA study of Traumatic Brain Injury and Concussion, Intermediate, sponsored by Indiana University.

Active
Registry status
NA
Development phase
85
Enrollment target
1
Study location

NCT05636020 is a NA study of Traumatic Brain Injury and Concussion, Intermediate that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 85 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05636020, a NA study of Traumatic Brain Injury and Concussion, Intermediate, is active but no longer recruiting, sponsored by Indiana University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
85 participants
Enrollment target
1
Study location

Study Summary

Determine the feasibility, practicality, and early efficacy of a TeleRehab program (ICARE) to improve outcomes for persons with traumatic brain injury (TBI) in recognizing and responding to others' emotions alongside their care partner (CP).

Interventions

  • BEHAVIORAL ICARE Treatment

Study Locations (1)

Indiana

  • Indiana University School of Medicine - Indianapolis

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2023-03-15
Est. Completion 2026-10
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT05636020

The ClinicalTrials.gov registry entry for NCT05636020 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (69% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which ICARE Treatment is the first listed.

NCT05636020 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT05636020 about?

NCT05636020 is a clinical study titled "Intervention to Change Affect Recognition and Empathy". Determine the feasibility, practicality, and early efficacy of a TeleRehab program (ICARE) to improve outcomes for persons with traumatic brain injury (TBI) in recognizing and responding to others' emotions alongside their care partner (CP).

What is the current status of trial NCT05636020?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 85 participants. The study started on 2023-03-15. Estimated completion is 2026-10.

What conditions does trial NCT05636020 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Concussion, Intermediate, Concussion, Severe, Traumatic Brain Injury With Loss of Consciousness, Concussion With LOC 31 to 59 Minutes.

What interventions are being tested in trial NCT05636020?

The interventions under investigation include: ICARE Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT05636020?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05636020 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.